Sara Cajander Selected Research

Anti-Bacterial Agents (Antibiotics)

10/2017

[Melioidosis, an important diagnosis in the severely ill traveler].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sara Cajander Research Topics

Disease

9	Sepsis (Septicemia) 12/2023 - 10/2013
8	COVID-19 05/2024 - 11/2020
7	Inflammation (Inflammations) 05/2024 - 01/2018
4	Infections 05/2024 - 10/2017
3	Respiratory Insufficiency (Respiratory Failure) 11/2023 - 01/2022
2	Bacteremia 01/2018 - 10/2017
1	Communicable Diseases (Infectious Diseases) 05/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Hypersensitivity (Allergy) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Heart Failure 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020
1	Pneumonia (Pneumonitis) 08/2019
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Cross Infection (Nosocomial Infection) 10/2013

Drug/Important Bio-Agent (IBA)

4	Messenger RNA (mRNA)IBA 05/2024 - 10/2013
3	VaccinesIBA 05/2024 - 04/2021
3	Oxygen (Dioxygen)IBA 11/2023 - 01/2022
3	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 10/2013
3	HLA-DR alpha-ChainsIBA 10/2017 - 10/2013
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2019
2	C-Reactive ProteinIBA 03/2019 - 01/2018
1	BNT162 VaccineIBA 05/2024
1	CytokinesIBA 05/2024
1	mRNA VaccinesIBA 05/2024
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	camostatIBA 05/2021
1	Serine Proteases (Serine Protease)IBA 05/2021
1	Hyaluronic Acid (Hyaluronan)IBA 11/2020
1	Secretory Leukocyte Peptidase InhibitorIBA 08/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016
1	MHC class II transactivator proteinIBA 01/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2013

Therapy/Procedure

2	Critical Care (Surgical Intensive Care) 11/2023 - 01/2021
1	Precision Medicine 12/2023
1	Therapeutics 11/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Percutaneous Coronary Intervention 01/2021
1	Stents 01/2021